Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.6737
0.00 (0.00%)
At close: Jul 22, 2026

Mosaic ImmunoEngineering Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
000.120.160.220.23
Cash & Short-Term Investments
000.120.160.220.23
Cash Growth
-99.92%-96.85%-26.35%-29.22%-2.43%-40.55%
Prepaid Expenses
0.010.020.030.020.040.04
Total Current Assets
0.010.020.140.180.260.27
Total Assets
0.010.020.140.180.260.27

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.170.130.130.120.130.11
Accrued Expenses
5.635.525.034.443.561.94
Short-Term Debt
0.20.20.2---
Other Current Liabilities
0.180.180.180.180.220.28
Total Current Liabilities
6.186.035.544.733.922.33
Long-Term Debt
1.481.471.391.321.230.74
Total Liabilities
7.667.56.936.055.153.07

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
2.052.052.052.052.021.73
Retained Earnings
-9.7-9.53-8.84-7.92-6.91-4.53
Total Common Equity
-7.65-7.48-6.79-5.87-4.88-2.8
Shareholders' Equity
-7.65-7.48-6.79-5.87-4.88-2.8
Total Liabilities & Equity
0.010.020.140.180.260.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.681.671.591.321.230.74
Net Cash (Debt)
-1.68-1.66-1.48-1.16-1.01-0.51
Net Cash Growth
------
Net Cash Per Share
-0.23-0.23-0.20-0.16-0.14-0.08
Filing Date Shares Outstanding
7.247.247.247.247.247.24
Total Common Shares Outstanding
7.247.247.247.247.247.24
Working Capital
-6.17-6.01-5.4-4.55-3.66-2.06
Book Value Per Share
-1.06-1.03-0.94-0.81-0.67-0.39
Tangible Book Value
-7.65-7.48-6.79-5.87-4.88-2.8
Tangible Book Value Per Share
-1.06-1.03-0.94-0.81-0.67-0.39